Global Epigenetics Market Size To Grow USD 10.55 Billion By 2030 | CAGR of 17%

Global Epigenetics Market Size To Grow USD 10.55 Billion By 2030

According to a research report published by Spherical Insights & Consulting, the Global Epigenetics Market Size to grow from USD 2.57 billion in 2021 to USD 10.55 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 17% during the forecast period.  One of the most important aspects that are contributing to the expansion of the epigenetics market is the rising incidence of cancer and acquired immune deficiency syndrome (AIDS) all over the world. In addition, the widespread implementation of epigenetic treatments for conditions that aren't related to cancer is a driving force behind the expansion of the industry.

Browse key industry insights spread across 190 pages with 137 market data tables and figures & charts from the report “Global Epigenetics Market Size, Share, and COVID-19 Impact Analysis, By Product (Kits and Reagents, Instruments, and Others), By Application (Metabolic Diseases, Oncology, CNS/Pain Diseases, Autoimmune Diseases, Cardiovascular Diseases), By Technology (Methylation, Phosphorylation, Acetylation, Other Technologies) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030” in detail along with the table of contents https://www.sphericalinsights.com/reports/epigenetics-market

View a detailed Table of Content here

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

The Kits and Reagents segment to account for the largest market size during the forecast period

Based on the product, the Epigenetics Market is categorized into Kits and Reagents, Instruments, and Others. The Kits and Reagents segment accounts for the largest market size during the forecast period. It is anticipated that the kits and reagents category would have the greatest market among all other segments. Epigenetic diagnostic kits are utilized for the early-stage diagnosis of illnesses resulting from epigenetic alterations, as well as for monitoring the therapeutic efficiency of treatments while they are being administered.

The Oncology segment to hold a higher CAGR during the forecast period

Based on application, the Epigenetics Market is categorized into Metabolic Diseases, Oncology, CNS/Pain Diseases, Autoimmune Diseases, and Cardiovascular Diseases. The Oncology segment to hold higher CAGR during the forecast period. Oncology is the field that contributes the most money to the whole market. The rise in the global incidence of cancer is one factor that is contributing to the expansion of this market sector. In addition, it is anticipated that the launch of brand-new items and the possible commercialization of products that are already in the production line will serve as a catalyst for the expansion of this market segment.

The Methylation segment is to hold a higher CAGR during the forecast period.

Based on technology, the Epigenetics Market is categorized into Methylation, Phosphorylation, Acetylation, and Other Technologies.  The Methylation segment is to hold a higher CAGR during the forecast period. The methylation segment is responsible for the largest proportion of revenue in the epigenetics market. It is anticipated that the high cost of maintenance of methylation technology used for epigenetic studies impedes the growth of this market segment.

Asia-Pacific to hold a higher CAGR during the forecast period.

The Global Epigenetics Market has been segmented into five major regions: Asia-Pacific, Europe, APAC, Latin America, and MEA. North America is estimated to account for the highest market share in 2022. The market for epigenetics in the North American region has been expanding owing to the increasing rising R&D activities by several small and medium enterprises to develop medical healthcare facilities in the healthcare sector. In addition, the expansion of the region's healthcare facilities and the development of new diagnostic procedures are some of the factors that are driving the growth of the regional market. There has been a general rise in patients' knowledge of the availability of innovative goods, which is another aspect that has contributed to the region's preeminent market position.

Major vendors in the Global Epigenetics Market include Abcam PLC, Active Motiff, Hologic Inc (Diagenode Inc.), F. Hoffmann-La Roche Ltd, Illumina Inc., Qiagen NV

Recent Development

• In February 2022, a trial being sponsored by the National Cancer Institute (NCI), which is part of the National Institutes of Health, reported the dosing of the first patient with a combination of Bristol Myers Squibb's PD-1 immune checkpoint inhibitor OPDIVO and YERVOY and Zenith Epigenetics Ltd.'s ZEN-3694 (BET inhibitor) solid tumor cancer.

• In February 2022, Dovetail Genomics and Element Biosciences, Inc. entered into a partnership to demonstrate the value and performance of Dovetail's proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element's AVITI System. Element Biosciences, Inc., the developer of a new and disruptive DNA sequencing platform, initiated this partnership.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global epigenetics market based on the below-mentioned segments:

Global Epigenetics Market, By Product

• Kits and Reagents
• Instruments
• Others

Global Epigenetics Market, By Application

• Metabolic Diseases
• Oncology
• CNS/Pain Diseases
• Autoimmune Diseases
• Cardiovascular Diseases

Global Epigenetics Market, By Technology

• Methylation
• Phosphorylation
• Acetylation
• Other Technologies

Global  Epigenetics Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa